PRKDC and hepatocellular carcinoma: Meanwhile, we showed that KU-0060648 was more potent than traditional DNA-PKcs inhibitors (NU-7441 [32] and NU-7026 [33]) in inhibiting HCC cells (Supplementary Figure S2A and 2B).